News for Healthier Living

Revalesio to Present Findings from a Post-Hoc Analysis of Phase 2 RESCUE Trial at SVIN 2025, Highlighting RNS60's Potential to Shorten Hospital Stay

Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute and chronic neurological disorders, announced today that findings from a post hoc analysis of its Phase 2 RESCUE trial will be presented as an oral presentation at the Society of Vascular and Interventional Neurology (SVIN) Annual Meeting, taking place November 19-22, 2025, in Orlando, Florida.

November 19, 2025


November 19 2025

November 18 2025

November 17 2025

November 16 2025

November 15 2025

November 14 2025

November 13 2025

November 12 2025

November 11 2025

November 10 2025

November 9 2025

November 8 2025

November 7 2025

November 6 2025

November 5 2025